Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung

7680616860026 CH-61686 Hartkapseln mit veränderter Wirkstofffreisetzung

Associated product:

ORACEA caps ret 40 mg 56 pce
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
56
Selling units
56
Measure
Kapsel(n)
Galenic form
Hartkapseln mit veränderter Wirkstofffreisetzung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/02/2026
Patient information leaflet
Français
15/02/2026
Patient information leaflet
Italien
15/02/2026
Summary of Product Characteristics
Allemand
15/02/2026
Summary of Product Characteristics
Français
15/02/2026
Summary of Product Characteristics
Italien
15/02/2026

Detailed composition

Substance Quantity Type Category
doxycyclinum
40.0 MG Substance Wirkstoff (Principe actif)
doxycyclinum monohydricum
41.62 MG Substance WIZUS
sacchari sphaerae
- Substance HNIDK
maydis amylum
- Substance HNIDK
saccharum
150.36 MG Substance HBESI
hypromellosum
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
triethylis citras
- Substance HNIDK
talcum
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polysorbatum 80
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (nigrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 132
- Substance FIMDK
E 129
- Substance HBESI
E 133
- Substance FIMDK
E 104
- Substance FIMDK

Reimbursement information

Public price
CHF 50.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2013

Authorization holder

Galderma SA

6300 Zug

Authorization information

Swissmedic authorization number
61686
Drug name
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Galenic form
KAHA
ATC Code
J01AA02
Authorization status
Z
Dispensing category
A
First authorization
15/03/2012
Authorization expiration date
31/12/9999
IT Number
08.01.5.
Domain
Human medicine
Field of application
Rosazea

Package details

Description (FR)
ORACEA caps ret 40 mg 56 pce
Description (DE)
ORACEA Ret Kaps 40 mg 56 Stk
Market launch
15/03/2012
Narcotic (BTM)
No

Available generics (10)

Doxyclin, Tabletten
GTIN: 7680440000605
CHF 13.35
View
Doxyclin, Tabletten
GTIN: 7680440000612
CHF 31.85
View
Doxyclin, Tabletten
GTIN: 7680440000339
CHF 16.45
View
Doxycyclin-Mepha, Tabletten
GTIN: 7680659520017
CHF 25.55
View
Doxycyclin-Mepha, Tabletten
GTIN: 7680659520024
CHF 14.15
View
Doxycyclin-Mepha, Tabletten
GTIN: 7680659520031
CHF 17.60
View
Doxylag 100, capsules
GTIN: 7680426880016
CHF 14.25
View
Doxylag 100, capsules
GTIN: 7680426880023
CHF 38.60
View
Doxysol, Tabletten
GTIN: 7680507480302
CHF 13.30
View
Doxysol, Tabletten
GTIN: 7680507480494
CHF 15.95
View

Other package sizes (1)

ORACEA caps ret 40 mg 28 pce
28 KAP
GTIN: 7680616860019
View
Buy us a coffee Explore the data